[EN] IAP INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINES D'APOPTOSE
申请人:TETRALOGIC PHARMACEUTICAL CORP
公开号:WO2009094287A1
公开(公告)日:2009-07-30
The present invention describes compounds of the following formula: processes for their preparation, pharmaceutical compositions containing them, and their use in therapy. The compounds of the present invention inhibit IAPs (inhibitors of apoptosis proteins) and thus are useful in the treatment of cancer, autoimmune diseases and other disorders where a defect in apoptosis is implicated.
Reactions of β-(lithiomethyl)azines with nitriles as a route to pyrrolo-pyridines, -quinolines, -pyrazines, -quinoxalines and -pyrimidines
作者:Michael L. Davis、Basil J. Wakefield、Jacklyn A. Wardell
DOI:10.1016/s0040-4020(01)88196-5
日期:——
Deprotonation of 3-methylazines, followed by reaction with benzonitile, gives an intermediate which, on treatment with additional strong base, cyclises to give 2-phenyl[1H]-pyrrolo[2,3-b]pyridine. The application of this type of reaction to a variety of nitriles and β-methylazines (pyridines, quinolines, pyridines, quinoxalines and pyrimidines) is described.